Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.260
+0.090 (2.16%)
At close: Dec 5, 2025, 4:00 PM EST
4.250
-0.010 (-0.23%)
After-hours: Dec 5, 2025, 5:55 PM EST
Adverum Biotechnologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 94 | 97 | 76 | 58 | 173 | 1,057 | |
| Market Cap Growth | -34.00% | 27.74% | 31.60% | -66.55% | -83.65% | 42.01% | |
| Enterprise Value | 157 | 17 | 34 | -40 | -38 | 633 | |
| Last Close Price | 4.26 | 4.67 | 7.53 | 5.79 | 17.60 | 108.40 | |
| PS Ratio | - | 97.15 | 21.13 | - | 23.03 | - | |
| PB Ratio | - | 1.37 | 1.13 | 0.32 | 0.55 | 2.43 | |
| P/TBV Ratio | - | 1.37 | 1.13 | 0.32 | 0.55 | 2.43 | |
| EV/Sales Ratio | - | 17.17 | 9.58 | - | - | - | |
| Debt / Equity Ratio | -1.60 | 1.30 | 1.10 | 0.59 | 0.33 | 0.07 | |
| Asset Turnover | - | 0.01 | 0.02 | - | 0.02 | - | |
| Quick Ratio | 0.58 | 5.49 | 4.83 | 5.76 | 14.58 | 20.59 | |
| Current Ratio | 0.65 | 5.73 | 5.14 | 5.91 | 14.88 | 20.82 | |
| Return on Equity (ROE) | -417.79% | -189.84% | -98.19% | -62.10% | -38.78% | -38.57% | |
| Return on Assets (ROA) | -76.89% | -51.83% | -34.73% | -25.11% | -19.66% | -20.90% | |
| Return on Capital (ROIC) | -94.11% | -57.28% | -37.52% | -26.56% | -20.51% | -21.93% | |
| Return on Capital Employed (ROCE) | -682.50% | -88.70% | -95.00% | -54.40% | -34.70% | -25.50% | |
| Earnings Yield | -196.48% | -134.77% | -160.57% | -267.40% | -84.25% | -11.12% | |
| FCF Yield | -147.20% | -95.58% | -120.59% | -207.48% | -71.17% | -8.63% | |
| Buyback Yield / Dilution | -26.37% | -96.21% | -1.58% | -1.24% | -15.14% | -32.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.